Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus (Q45759631)
scientific article published on November 1, 1997
Language:
(P31) (Q13442814)
(P304) 1215-1224
(P407) (Q1860)
(P433) 5
(P478) 176
(P577) Saturday, November 1, 1997
Saturday, November 1, 1997
(P921) (Q79460)
(Q422248)
(Q12902725)
(P953) https://academic.oup.com/jid/article-pdf/176/5/1215/2477581/176-5-1215.pdf
http://academic.oup.com/jid/article-pdf/176/5/1215/2477581/176-5-1215.pdf
(P1433) (Q4051141)
(P1476) "Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus" (language: en)
"Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus" (language: en)
(P2093) S. Johnson
C. Oliver
G. A. Prince
V. G. Hemming
D. S. Pfarr
S. C. Wang
M. Dormitzer
J. O'Grady
S. Koenig
J. K. Tamura
R. Woods
G. Bansal
D. Couchenour
E. Tsao
W. C. Hall
J. F. Young
other details
description scientific article published on November 1, 1997

External Links